Submit a paper PCR replay PCR online

• 
• 
• 

EuroIntervention » Supplement E

A turning point for EuroPCR
Jean Marco, Chairman of EuroPCR
Patrick W. Serruys, Editor-in-Chief, EuroIntervention
William Wijns, President, EAPCI

The mission of the European Association for Percutaneous Cardiovascular Interventions is "to reduce the burden of cardiovasculardisease in Europe". Education is a vital part of the mission.
Launched for the first time in 2009, this EAPCI initiative resulted in the submission of 564 abstracts, with 255 of these being integrated into the scientific programme of EuroPCR as oral presentations.
An outstanding response for the first year – with submissions from 95 countries, the abstracts were a successful step in the ongoing evolution of the Course, and the fruit of a collaboration between the EAPCI, EuroIntervention and EuroPCR.
Peer-reviewed by a panel comprising both the EAPCI and the Editorial Board of EuroIntervention, the abstracts were of high scientific quality and covered an extremely broad subject range–reflecting the fact that EuroPCR draws from the entire cardiovascular community.
The 223 abstracts contained in the pages that follow will provide you with an overview of the abstract sessions scheduled over the four days of the Course. They are witness to the growth of EuroPCR, the spirit of openness, and the objective of a more inclusive Course programme.
We invite you not only to keep this first edition of the EuroIntervention Supplement Abstract Book as a reference – but toactively participate in the sessions, with topics including bifurcation lesions, transcatheter aortic valve implantation, diabetes, new devices, critical limb ischemia, the latest polymer technology and much more.
We aim to increase the presence of abstracts in the scientific programme of EuroPCR in 2010, and hope to receive an ever increasing response to what is one of the fundamentals of the education – and information process our profession is so closely tied to.
Our sincere thanks to all of those who participated in the grading of the abstracts, and worked to tight deadlines to ensure this publication made it to print!

• Out-of-the-box innovations
  • First clinical studies of an implantable device to detect ST-segment shifts and alert patients to cardiac ischemia
    Fischell D, Avezum A, Piegas L, Medeiros P, Gibson M, Holmes D, Kovach R, Kabell G, Fischell T
    The Coherex FlatStent: closure inside the patent foramen ovale
    Jones R, Horst Sievert H, Ruygrok P, Grube E, Schofer J
    Intracoronary navigation and positioning using the MediGuide gMPS enabled GMC system
    Weisz G, Wong D, Rabbani L, Collins M, Stone G, Leon M, Moses J
    The Heart Stitch pilot study: a novel transcatheter suture technique for patent foramen ovale closure
    Walker N, Asgar A, Khan A, Mullen M
    Quantitative evaluation of an elastic stent enhancement technique in x-ray image sequences
    Funck F, Guillard N, Bismuth V, Vaillant R
• Percutaneous intervention in very high risk patients
  • Life support and cardiac arrest
    Manzo-Silberman S, Mathonnet A, Varenne O, Cariou A, Spaulding C
    Percutaneous left ventricular assist device prevents cerebral ischemia during cardiac arrest
    Tuseth V, Pettersen R, Epstein A, Grong K, Husby P, Farstad M, Wentzel-Larsen T, Nordrehaug J
    Percutaneous left ventricular assist device comparable to open chest cardiac massage in ischemic cardiac arrest
    Tuseth V, Pettersen R, Grong K, Wentzel-Larsen T, Haaverstad R, Fannelop T. , Nordrehaug J
    PCI during ongoing cardio-pulmonary resuscitation
    Luijten H, van Grunsven P, Bos H, Gehlmann H, Meursing B, Oude-Ophuis T, Smeets J
    Minimally invasive catheter based cardiac assist device for cardiopulmonary support during high-risk percutaneous coronary interventions
    Konorza T, Iliodromitis K, Kaelsch H, Plicht B, Aidonidis G, Eggebrecht H, Erbel R
• The latest in polymer research
  • Scanning electron microscopic assessment of drug-eluting stents with durable coatings
    Basalus M, Ankone M. , Van Houwelingen G, Haf De Man F, von Birgelen C
    Novel thin-strut, bioabsorbable sol-gel coated, low-dose paclitaxel-eluting stent: evaluation in porcine coronary arteries
    Li J, Shinke T, Pendyala L, Geva S, Chen J, Yin X, Venegoni A, Colley K. , Chronos N, Robinson K, Hou D
    Effect of different polymer carrier on the long-term efficacy of sirolimus eluting stent in the treatment of coronary bifurcation lesions in elderly
    Lu C, Wang S, Zhang Y, Xue Q, Wu X
    The balance between polymer degradation and drug concentration determine the neointimal response to stents eluting tacrolimus from a biodegradable polymer coating up to 1 year post stenting
    Sorop O, van der Giessen W, Wentzel J, Duncker D, van Beusekom H
    Evaluation of BA9-eluting biodegradable PLA coating durability under simulated-use conditions: on the bench and in animal bifurcations
    Yazdani S, Grant G, Schulze J, Kolodgie F, Virmani R
    Anti-proliferative drugs on DES platforms reduce acute stent thrombogenicity
    Nguyen K, Pacetti S
• Primary percutaneous coronary intervention for STEMI and N-STEMI - Part I
  • Efficacy of rheolytic thrombectomy in patients with high thrombus burden during primary percutaneous coronary intervention
    Bellini F, De Carlo M, Gistri R, Ciabatti N, Borelli G, Giannini C, Donne M, Petronio A
    Assessment of intracoronary Abciximab bolus administration on infarct size reduction in patients treated by primary percutaneous coronary intervention in the acute phase of a first myocardial infarction
    Durel N, Monzy S, Ernande L, Muliez A, Morand D, Lipiecki J
    Deferral of PCI and pharmacological modification of thrombotic burden in patients with large intracoronary thrombus
    Gorgadze T, Aleong G, del Valle R, Hernandez-Antolin R, Jimenez-Quevedo P, Alfonso F, Garcia E, Macaya C, Banuelos C, Escaned J
    Optimal treatment of intracoronary thrombosis with local abciximab infusion through the Clearway system
    Prati F, Pawlosky T, La Manna A, Capodanno D, Ramazzotti V, Mcafoos J, Tamburino C, Gil R
    Enhanced platelet activity and delayed clopidogrel response during elective percutaneous coronary intervention after thrombolysis treatment for acute myocardial infarction
    Diego A, De Miguel A, De Prado A, Carlos C, Martin J, Fraile E, Bangueses R, Vega B, Fernandez-Vazquez F
• Innovative coronary devices - Part I
  • Development of a novel sirolimus eluting pro-healing stent: an optical coherence tomography-histology correlation study in the porcine coronary model
    Granada J, Leon M, Kaluza G, Inami S, Wallace-Bradley D, Tellez A, Aboodi M, Conditt G, Cheng Y, Yi H, Rowland S, Parker S, Kolodgie F, Nakazawa G, Virmani R
    Bioresorbable stent technology with preserved molecular weight
    Van Der Leest M
    Endothelial progenitor cell (EPC) capture in stented porcine coronary arteries increases endothelialisation but does not affect intimal thickening
    van Beusekom H, Ertas G, Sorop O. , Peters I, Serruys PW, van der Giessen W
    Long term safety and bio-absorption of a fully bio-absorbable everolimuseluting vascular implant in porcine and rabbit arterial models
    Powers J, Boeke-Purkis K, Perkins L, Stringer S, Coleman L, Rapoza R
    An ultrathin MarTyN stent allows early endothelialisation
    Vorpahl M, Virmani R
• Percutaneous mitral valve treatment
  • Procedural echocardiographic results from the TITAN trial
    Haude M, Sadowski J, Hoppe U, Fajadet J, Lipiecki J, Siminiak T
    Transcatheter repair of mitral valve regurgitation with mitraclip system: early single center experience
    Ussia G, Barbanti M, Scandura S, Mangiafico S, Scarabelli M, Cammalleri V, Mule M, Imme S, Tamburino C
    Percutaneous treatment of functional mitral repair. 2-years results from the EVOLUTION I study.
    Harnek J, Webb J, Kuck K, Buller C, Paushinger M, Tiefenbacher C, James S, Stone G, Vahanian A
    Percutaneous trans-coronary-venous repair of functional mitral regurgitation using CARILLON™ Mitral Contour System: the European experience
    Siminiak T, Hoppe U, Schofer J, Haude M, Herrman J, Vainer J, Firek L, Jerzykowska O, Van Bibber R
    Percutaneous pulmonary valvoplasty using JOMIVA balloon: a novel costeffective procedure
    Mishra C, Behera M, Mishra A, Routray S, Mishra H
    Cerebral microemboli during percutaneous mitral valvotomy for rheumatic mitral stenosis
    Natarajan D, Kohli A
• Randomised clinical trial updates
  • Four year follow-up of the typhoon study, a randomised trial comparing the sirolimus-eluting stent to bare metal stents during primary pci for acute myocardial infarction
    Spaulding C, Commeau P, Tirouvanziam A, Fajadet J, Stella P, Lefevre T, Abildgaard U, Merkely B, Cebrian A, Henry P
    Randomised comparison of titanium-nitride oxide stent versus stainless steel stent for coronary percutaneous intervention. 3 years follow-up from the RIO trial
    Sant’Anna F, Batista L, Brito M, Menezes S, Barrozo C
    Two year follow-up of the Endothelial Progenitor Cell capturing stent versus a paclitaxel-eluting stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: the single-center randomised TRIAS study
    Beijk M, Klomp M, Verouden N, Koch K, Henriques J, Baan J, Vis M, Scheunhage E, Piek J, Tijssen J, de Winter R
    Randomised trial comparing the Endeavor zotarolimus-eluting stent and the driver bare-metal stent in single de novo native coronary artery lesions: five-year clinical follow-up of ENDEAVOR II
    Wijns W, Fajadet J, Laarman G, Kuck K, Ormiston J, Munzel T, Popma J, Fitzgerald P, Bonan R, Kuntz R
    NOBORI 1- Long term results: two years phase 1&2 and three years phase 1
    Chevalier B, Silber S, Garcia E, Wijns W, Worthley S, Meredith I, Suryapranata H, Hauptmann K, Schuler G, Thuesen L
    Long term efficacy outcomes following treatment with zotarolimus-eluting stents: analysis of the pooled Endeavor programme
    Kandzar D, Leon M, Mauri L, Cutlip D, Wijns W, Fajadet J, Meredith I
• Platelet inhibition: key issues in percutaneous coronary intervention
  • A randomised pilot trial for aggressive therapeutic approaches in aspirin resistant patients undergoing percutaneous coronary intervention (RESIST TRIAL)
    Sarkar K, Ivan O, Suleman J, Krishnan P, Kim M, Sharma S, Kini A
    Diabetes mellitus is associated with inadequate platelet inhibition after clopidogrel measured by a point-of-care assay and with poorer periprocedural outcome in patients undergoing percutaneous coronary intervention
    Mangiacapra F, Patti G, Gatto L, Vizzi V, Ricottini E, Nusca A, D'Ambrosio A, Di Sciascio G
    Platelet reactivity assessed by flow cytometric VASP phosphorylation is an independent predictor of death and cardiovascular death in unselected patients undergoing percutaneous coronary intervention
    El Ghannudi S, Ohlmann P, Wiesel M, Radulescu B, Bareiss P, Chauvin M, Gachet C, Morel O
    Thrombogram in acute coronary syndrome patients pretreated with a combination of antiplatelet agents and fondaparinux
    Schiele F, Meneveau N, Seronde M, Chopard R, Descotes-Genon V, Duteil J, Mrabet K, Bassand J
    Glycoprotein IIbIIIa inhibitors improve outcome after coronary stenting in clopidogrel non responders: a prospective, randomised study
    Cuisset T, Frere C, Poyet R, Quilici J, Bali L, Alessi M, Bonnet J
    CYP2C19*17 allele is associated with better response to clopidogrel
    Cuisset T, Frere C, Poyet R, Quilici J, Gaborit B, Bali L, Morange P, Alessi M, Bonnet J
• Percutaneous coronary intervention and coronary bifurcation lesions: novelties - Part I
  • The dogbone technique: a novel approach to standardise and optimise stent deployment in Medina 0.0.1 and T-stenting
    ManfredZehetgruber M, Pausa B, Kratochwill C, Enzenhofer E
    The \"OstialPro™\" stent positioning device: a tool for precise aorto-ostial stent placement
    Fischell D, Fischell T, Fischell R
    Bifurcation balloon and stent platform to simplify and optimise bifurcation interventions
    Kaluski E, Gerula C, Maher J, Klapholz M
    Virtual investigation of a novel provisional bifurcation stent system
    Mortier P, Weber J, De Beule M, De Santis G, Segers P, Verdonck P, Verhegghe B
    Evaluation of Pathfinder, an everolimus eluting dedicated bifurcation stent in a porcine coronary stenting model in comparison with XIENCE V™ coronary stent
    Sorop O, van Beusekom H, Krabbendam S, Krabbendam I, Boeke-Purkis K, van der Giessen W
• The latest in polymer research
  • Jailing wires in bifurcation disease; is it safe? Evidence from an ex-vivo model
    Prinja D, Butler R
• Biomarkers: key issues in percutaneous coronary intervention
  • Serum creatinine concentration is an independent predictor of long-term mortality following percutaneous coronary intervention, drug-eluting stent implantation may reduce this risk
    Alahmar A, Alkarmi A, Perry R
    Basal peripheral endothelial dysfunction correlates with on-treatment platelet reactivity
    Muller O, Hamilos M, Bartunek J, Ulrichts H, de Bruyne B, Holz J, Ntalianis A, Vercruysse K, Trana Berza C, Mangiacapra F, Wijns W, Barbato E
    Are paclitaxel-eluting stents anti-inflammatory?
    Ochala A, Wojakowski W, Tendera M
    Investigation to vascular endothelial function of patients who suffered from vasospastic angina
    Ito S, Yamamoto M, Hara H, Moroi M, Nakamura M
    Metabolic syndrome is a key determinant of coronary microvascular function in patients with stable coronary disease undergoing PCI
    Melikian N, Shah A, Thomas M, Byrne J, Sherwood R, Kearney M, MacCarthy P
• Cost effectiveness in percutaneous coronary intervention
  • Cost-effectiveness of paclitaxel and bare-metal stents in the real world
    Ferreira E, Amorim B, Ferreira Jr A, Vargues Rodrigues C, Valentim A, Quintela E, Junqueira C, Farias M, Farias Neto A, Pimentel Palazzo J, Maluly V, Albuquerque D, Azevedo V, Vianna D
    Long-term outcomes with drug-eluting stents versus cobalt-chromium stents. Findings from the REAL Registry
    Menozzi M, Ortolani P, Guastaroba P, Marzaroli P, Vignali L, Magnavacchi P, Marzocchi A, Manari A
    Feasibility of ambulatory diagnostic and interventional coronary procedures in patients with stable heart disease
    Battistini A, Uguccioni L, Marinucci L, Uguccioni S, Canestrari E, Fattori S, Ferretti C, Maffei K, Mattioli M, Mazzilli L, Montesi P, Ricciardelli P, Binetti G
    Economic evaluation of drug-eluting stents vs. bypass surgery for patients with 3-vessel and left main coronary artery disease: 1-year results from the SYNTAX trial
    van Hout B, Bojke C, Cohen D, Audi S, Serruys PW, Mohr F, Dawkins K, Kappetein A
• Innovation in peripheral intervention
  • Development of in-hospital microangiography for evaluation of limb ischemia
    Mori H, Ikeya Y, Fukuyama N, Fujii T, Chiku M, Takeshita S, Nishigami K, Tsutumi Y
    Luminal area stenosis calculation for peripheral self-expanding stents in pre-clinical studies
    Zhao H, Nikanorov A, Virmani R, Schwartz L
    Understanding patient-specific virtual reality endovascular simulation
    Willaert W, Aggarwal R, Van Herzeele I, O'Donoghue K, Kabbar M, Gaines P, Vermassen F, Darzi A, Cheshire N
    A new modular embolic protection system: first in man experience
    Scheinert D, Rosenchein U, Ulrich M, Braunlich S, Schmidt A
    Animal evaluation of a novel alternating helical stent
    Zeller T, Johnson A, Cheng C, Martin G
• New drug-eluting stents - FIM
  • Stellium 1: first in man 12 month clinical follow-up results
    Hellig F, Conway D
    First-in-man study of a novel polymer-free low-dose paclitaxel eluting stent - one year follow-up
    Calderas C, Condado J, Fitzgerald P, Waseda K, Nakatani D, Flores A, Mueller A, Thomas J
    Long-term (> 1 year) results of the third generation hydroxyapatite nonpolymer- based sirolimus-eluting stent for the treatment of single de novo coronary lesions
    De Ribamar Costa Jr J, Abizaid A, Costa R, Feres F, Tanajura L, De Ribamar Costa J, Costa J
    BioFreedom™ polymer-free DES. Preclinical results and FIM trial status
    Tada N, Virmani R, Grant G, Bartlett L, Black A, Clavijo C, Christians U, Betts R, Savage D, Buellesfeld L, Kar S, Grube E
    Complex patients with coronary artery disease treated with the novel supralimus sirolimus-eluting stents. Preliminary results of the prospective, multicenter, non-randomised E-Series trial
    Costa R, Abizaid A, De Ribamar Costa Jr J, Feres F, Arruda J, Prudente M, Machado B, Brito F, Teixeira Jr C, Costantini C, Perin M, Ribeiro E
• Transcatheter aortic valve implantations - Part I
  • 18 months single center experience with the CoreValve prosthesis in 157 patients: procedural complications, valve-related events and survival
    Bleiziffer S, Ruge H, Mazzitelli D, Hutter A, Opitz A, Hettich I, Bauernschmitt R, Lange R
    Aortic annulus measurements with transthoracic and transesophageal echocardiography in transcatheter aortic valve implantation
    Hutter A, Opitz A, Bleiziffer S, Ruge H, Mazzitelli D, Hettich I, Kornek M, Tassani-Prell P, Bauernschmitt R
    Measurement of the aortic annulus in patient selection for transcatheter aortic valve implantation
    Walker N, Delahunty N, Moat N, Mullen M
    30 day and 6 month outcomes from IP003: the Direct Flow medical percutaneous aortic valve trial for the treatment of patients with aortic stenosis
    Schofer J, Tubler T, Pascotto A, Treede H, Reichenspurner H, Low R, Bolling S
    A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of severe aortic stenosis: a two-center propensity score analysis study
    Piazza N, van Gameren M, Wenaweser P, Carrel T, Onuma Y, Gahl B, Hellige D, Otten A, Kappetein A, Juni P, Takkenberg J, van Domburg R, de Jaegere P, Serruys PW, Windecker S
    Implemented procedural changes to enhance stabilization during transcatheter aortic valve replacement
    Fusari M, Bona V, Trabattoni P, Biglioli P
• Percutaneous peripheral interventions
  • Belgian Absolute trial: 3 year results
    Schroe H, Vermassen F, Coucke C, Randon C, Lauwers G, Lansink W, Jacobs B, Goffette P
    Limb salvage with percutaneous transluminal angioplasty for critical limb ischemia: a single-center experience based on an integrated care approach
    Pavei A, Leger P, Sauguet A, Oreglia J, Farah B, Fajadet J
    One year clinical outcomes of renal artery stenting: the results of ODORI registry
    Sapoval M, Tamari I, Goffette P, Downes M, Senechal Q, Fanelli F, Reimer P, Negaiwi Z, De Cassin P, Heye S, Korobov V, Abada H
    PTFE covered balloon expandable stents perform better in atherosclerotic iliac artery occlusive disease: clinical investigation and unique follow up with 64 bit CT scanner and Vitrea software
    Kumar V
• Transcatheter aortic valve implantations - Part II
  • Transcatheter aortic valve implantations - Part II
    Schiele F, Stiubei M, Meneveau N, Mrabet K, Blonde M, Descotes-Genon V, Seronde M, Bassand J
    Balloon aortic valvuloplasty - our experience in the transcatheter aortic valve implantation era
    Behan M, Nadra I, Dworakowski R, Wilson K, Redwood S
    Experience with 200 patients after transcatheter aortic valve implantation. When should the transapical approach be chosen?
    Ruge H, Bleiziffer S, Mazzitelli D, Hutter A, Opitz A, Tassani-Prell P, Bauernschmitt R, Lange R
    Electrocardiographic changes after insertion of CoreValve aortic valve revalving system
    Haworth P, Behan M, Hutchinson N, Trivedi U, Laborde J, Hildick-Smith D
    Co-existent significant coronary artery disease in severe aortic stenosis: should we treat it before a transcatheter aortic valve implant?
    Nadra I, Behan M, Dworakowski R, Wilson K, Thomas M
• New stents - FIM
  • First clinical experience with Misago peripheral self-expanding nitinol stent: MISAGO 1 clinical trial
    Schulte K, Müller-Hülsbeck S, Cao P, Becquemin J, Langhoff R, Charalambous N, Desgranges P, Kobeiter H, Midulla M, Beregi J
    Long term results of Polyzene-F stents coverage. Insights from the OCT subgroup of the ATLANTA FIM study
    Capodanno D, Prati F, La Manna A, Ramazzotti V, Albertucci J, Tamburino C
    Single center, first-in-man study of the Elixir novolimus eluting coronary stent system with durable polymer: 24-month clinical safety and efficacy results
    Ribamar Costa Jr J, Abizaid A, Feres F, Costa R, Seixas A, Maia F, Staico R, Siqueira D, Ormiston J, Sousa A, Fitzgerald P, Meredith L, Bhat V, Yan J, Sousa J
    Multi-center first-in-man study with the lowest known limus dose on the Elixir medical Myolimus™ eluting coronary stent system with a durable polymer: 12-month clinical and six month angiographic and IVUS follow-up
    Rutsch W, Schuhlen H, Witzenbichler B, Fitzgerald P, Meredith L, Bhat V, Yan J
    Preliminary experience with the novel MGuard stent system containing a protection net to prevent distal embolisation: results from the Inspire trial
    De Ribamar Costa Jr J, Abizaid A, Feres F, Costa R, Maia F, Esteves V, Staico R, Siqueira D, Maldonado G, Sousa A, Sousa J
    First-in-man study of simvastatin-eluting stent in de novo coronary lesions
    Zago A, Reginato L, Matte B, Krepsky A, Pereira L, F. Raudales M, J. Zago A
• Carotid artery stenting
  • The effect of age on the short and long-term outcome of carotid artery stenting
    Galasko G, Boesch C, Eberli F
    The role of prophylactic dopamine administration in preventing adverse events during carotid artery stenting.
    Palloshi A, Aprigliano G, Frigerio S, Bianchi M, Glavina F, Marchetti F, Bonizzato S, Scuteri L, Li Volsi L, Missora P, Rosa M, Finotti A, Gastaldi D, Anzuini A
    Endovascular recanalisation for chronic cervical internal carotid artery occlusion
    Lin M, Kao H
    BULgarian Carotid Artery Stenting versus Surgery Study (BULCASSS): Randomized single center trial. Late results.
    Petrov I, Kichukov K, Konteva M, Dimitrov C
    GORE EMPiRE clinical trial Results using the Gore Flow Reversal System during carotid artery stenting
    Schonholz C, Uflacker R
• Below the knee and critical limb ischemia
  • Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia as treatment of choice
    Donas K, Schwindt A, Pitoulias G, Schonefeld T, Torsello G
    Sustained patency after total chronic occlusive plaques by ablation with excimer laser in the treatment of critical limb ischemia in diabetic patients
    Serino F, Cao Y, Renzi C, Mascellari L, Platone A, Toscanella F, Damia S, Tempesta P, De Grandis M, Santini A
    Critical limb ischemia and multilevel disease: can be usefull the simple iliac recanalisation to determinate a clinical benefit in octagenarians?
    Setacci F, Sirignano P, de Donato G, Chisci E, Setacci C
    Usefulness skin perfusion pressure (SPP) in the evaluation of CLI after percutaneous angioplasty
    Sato T, Okahara K
    Long term results of plaque excision combined with aggressive pharmacotherapy in high risk population (SAVE A LEG Registry).
    Kiesz R, BuszmanP, Radvany M, Wiernek S, Szewc R, Nazarewicz G, Buszman P, Wiernek B, Martin J
• Gender differences in coronary artery disease
  • Gender differences in the incidence of epicardial coronary artery disease
    Ebrahimi R, Azmoon S, Ahmadi N, Budoff M
    Gender-based outcome after TITAN-2® stent and TAXUS-Liberte® stent implantation in patients with acute myocardial infarction
    Karjalainen P, Niemela M, Ylitalo A, Kervinen K, Makikallio T, Pietila M, Sia J, Tuomainen P, Nyman K, Airaksinen J
    Gender differences in stent thrombosis: insights from TAXUS WOMAN
    Mikhail G, Gerber R, Corbett S, Qasim A, Grube E, Stone G, Turco M, Levitt L, Dawkins K, Baim D, Colombo A
• Percutaneous valve repair
  • Findings from pulmonic implantation of the SAPIEN Valve (former THV) in animal models
    Felsen B, Hijazi Z, Olin J, Srimanne L, Khanna R, Chia C, Bash A, Keidar Y
    Percutaneous dilatation of the pulmonary arteries and combined selective lysis with urocinase and heparin as a new treatment option in patients with chronic embolic lung embolism
    Konorza T, Plicht B, Aidonidis G, Hartenstein S, Kaelsch H, Erbel R
    First-in-man percutaneous mitral repair with Mitralign system
    Ebner A, Buellesfeld L, Gallo S, Alvarez E, Silva E
    Retroflex 3: a new percutaneous valve delivery system: initial experience and outcome data
    Nietlispach F, Moss R, G. Carere R, Al-Bugami S, Masson J, Wijesinghe N, Webb J
    High Intensity Focus Ultrasound (HIFU) for mitral annulus reduction
    Bonan R, Shi Y, Zou Y, Ikeda A, Nakagawa H
• Understanding the role of endothelial function in the drug-eluting stent era
  • Comparison of endothelialisation and its function after stenting of established plaques in the rabbit iliac artery model
    Nakazawa G, Wilcox J, Melder R, Pruitt S, Vorpahl M, Kolodgie F, Virmani R
    A novel bioabsorbable oil-based stent coating as optimal vehicle for delivery of drugs
    van Langenhove G, Verheye S, Agostoni P, Vermeersch P, Benit E, Vrolix M, Desmet W, Cornelis K, Janssen L, Hanet C
    Normal vasomotor function with minimal inflammatory response to Cerivastatin-eluting stent in a rabbit iliac model
    Pendyala L, Goodchild T, Yin X, Li J, Shinke T, Geva S, Chen J, Chronos N, Robinson K, Hou D
    Early endothelialisation in Paclitaxel-eluting stents is similar to other drug eluting stents but shows transient endothelial dysfunction
    van Beusekom H, Sorop O, van Den Heuvel M, Onuma Y, Duncker D, Danser J, van der Giessen W
• Drug-eluting stent: miscellaneous
  • Multicentric Belgium/Netherlands Pro-Kinetic Safety and Efficacy Study (MULTIBeNe)
    Suttorp M, Vermeersch P
    Clinical usefulness of paclitaxel-eluting stent in dialysis patients with coronary artery disease: a comparison with sirolimus-eluting stent
    Otsuka M, Hayashi Y, Masaoka Y, Ueda H, Sakuma T, Muraoka Y, Hirao H, Toyofuku M, Okimoto T, Tamekiyo H, Takeda R, Mito S, Kawase T, Tokuyama T, Motoda C
    Occurrence of stent thrombosis and mace in the very long-term follow-up (> 4 years) of non-selected, complex patients: insights from the desirelate registry
    De Ribamar Costa Jr J, Sousa A, Moreira A, Costa R, Maldonado G, Cano M, Pavanello R, Carballo M, Campos Neto C, Berwanger O, Sousa E
    Everolimus-eluting stent in long lesions. The everlong multicenter registry
    Diaz J, Sanchez A, Moreu J, Duran J, Fernandez M, Tejedor P, Cardenal R, Canton T, Serrador A, Villa M, Pajin F, Robles J
• Trial and registry updates
  • Rates of stent thrombosis and major cardiac adverse events 36 months after simple versus complex stenting of coronary artery bifurcation lesions in the nordic bifurcation study
    Sjogren I, Lassen J, Steigen T, Wiseth R. , Erglis A, Kumsars I, Gunnes P, Mannsverk J, Meyerdierks O, Niemela M, Kervinen K, Jensen J, Galloe A, Nikus K, Vikman S, Ravkilde J, Aaroe J, Helqvist S, Thuesen L
    Early and late graft occlusion and stent thrombosis: analysis from the SYNTAX Trial
    Feldman T, Serruys PW, Mohr F, Morice M, Kappetein A, Holmes D, Stahle E, Colombo A, Leadley K, Dawkins K, Mack M
    Gemini angioplasty & arterial measurement evaluation: the multicenter GAAME trial
    van der Giessen W, Smits P, Saucedo J, Vos J, Weintraub A, Chang M, Regar E
    Impact of gender on three-year outcome following percutaneous coronary intervention using bare-metal and drug-eluting stent in de-novo coronary artery disease – Insights from the RESEARCH and T-SEARCH Registries
    Onuma Y, Kukreja N, Piazza N, Gonzalo N, Girasis C, Eindhoven J, van Domburg R, Serruys PW
    Eight-year outcomes after endovascular aortic repair (EVAR) Claudia D’Andrea1,
    D'Andrea C, Piscione F, Iannelli G, Di Tommaso L, Carolina D, Pierri A, Vosa C, Chiariello M
• Percutaneous coronary intervention and coronary bifurcation lesions: novelties - Part II
  • Drug eluting stents in bifurcations. Bench study of strut deformation and coating lesions
    Guerin P, Pilet P, Finet G, Goueffic Y, N'Guyen M, Crochet D, Tijou I, Pacaud P, Loirand G
    Short-and long-term results of T- versus culotte technique for the treatment of coronary bifurcations with sirolimus-eluting stent
    Aprigliano G, Palloshi A, Morici N, Bianchi M, Glavina F, Ceccarelli G, Scuteri L, Li Volsi L, Minardi G, Bonizzato S, Frigerio S. , Gastaldi D, Rosa , Anzuini A
    Three-year follow-up of 100 consecutive bifurcation lesions treated with taxus stents and the crush T-stent technique
    Chue C, Routledge H, Ludman P, Townend J, Epstein A, Buller N, Doshi S
    Szabo technique vs. conventional angiographic placement in bifurcations 010-001 and aorto-ostial lesions: safety and procedural results
    Gutierrez-Chico J, Villanueva-Benito I, Vazquez-Fernandez S, Kleinecke C, Gielen S, Iniguez-Romo A
    Predictor of plaque-shifting at side branch ostium during stent deployment in bifurcation. An intravascular ultrasound analysis
    Yamawaki M, Muramatsu T, Tsukahara R, Ito Y, Sakai T, Ishimori H, Sasao K, Nakano M, Hirano K, Araki M, Takimura H, Sakamoto Y
    Fate of side branch jailed by paclitaxel- and sirolimus-eluting stent
    Yamawaki M, Muramatsu T, Tsukahara R, Sakai T, Ishimori H, Sasao K, Nakano M, Hirano K, Araki M, Takimura H, Sakamoto Y
• Cell-based therapies - what's new?
  • The C-Cure clinical trial: a second-generation cell therapy for the treatment of ischemic cardiomyopathy
    Bartunek J, Vanderheyden M, Henry S, Wijns W, Terzic A
    3D imaging for selection of the target area for revascularisation and intracoronary stem cell transplantation 6 weeks after myocardial infarction
    Benedek T, Chitu M, Kovacs I, Sarbu A, Benedek I, Matei C, Szoke Z
    Second generation patient-derived stem cells for cardiac repair
    Behfar A, Yamada S, Crespo-Diaz R, Nesbitt J, Rowe L, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A
    First in man: feasibility and safety of intracoronary bone marrow derived stem cell injection in the sub acute phase post percutaneous coronary intervention for anterior myocardial infaction
    Locca D, Burchell T, Flett A, Yeo C, Wong J, Westwood M, Davis C, Martin J, Knight C, Rothman M, Aggrawal S, Mathur A
    Circulating stem cells as predictor of LVEF recovery in patients with acute MI treated with primary percutaneous coronary intervention in 12-months follow-up
    Wojakowski W, Wyderka R, Ochala A, Krol M, Buszman P, Kazmierski M, Smolka G, Klimeczek P, Hrycek E, Pasowicz M, Tendera M
• Drug-eluting stent: registry updates - Part I
  • SPIRIT V registry: one year follow-up
    Grube E
    Clinical outcomes post implantation of the paclitaxel-eluting stent in saphenous vein graft lesions in routine clinical practice: insights from the ARRIVE 1 and ARRIVE 2 registries
    Brilakis E, Berger P, Lasala J, Cox D, Starzyk R, Dawkins K, Baim D
    First 6 months report from the E-Select registry
    Urban P, Banning A, Abizaid A, Bartorelli A, Dzavik V, Ellis S, Gao R, Holmes D, Jeong M, Legrand V, Neumann F, Spaulding C, Worthley S
    Preserved long-term benefit of drug-eluting stents for off-label indications: a report from the NHLBI dynamic registry
    Marroquin O, Selzer F, Mulukutla S, Lee J, Smith C, Anderson W, Williams D, Kelsey S, Kip K
    Real world outcomes in patients with coronary artery disease treated with the endeavor ZES: 2-year results from the E-Five Registry
    Meredith I, Rothman M, Feres F, Zambahari R, Ferreira R, Heuer H, Lotan C
• Physiology of coronary artery disease
  • Influence of coronary artery lesion length on fractional flow reserve (FFR) across intermediate coronary lesions
    Alghamdi A, Alkhaldi A, Balghith M
    Resting Pd/Pa measured with pressure wire strongly correlates with fractional flow reserve
    Mamas M, Welch E, Ashworth A, Mellington S, Horner S, Neyses L, El-Omar M
    Clinical potential of three dimensional reconstruction for assessment of intermediate coronary artery lesions: a comparative study with pressure-derived fractional flow reserve
    Saad M, Toelg R, Abdel-Wahab M, Geist V, Richardt G
    Validation of an angiography based algorithm to calculate the coronary flow reserve
    Rittger H, Kuper A, Breithardt O, Sinha A, Schmidt M, Bluem B, Brachmann J
    Intracoronary beta blockers on dynamic recruitment of coronary collaterals: an interventional, randomised, double-blind study
    De Candia S, Egidy-Assenza G, Berni A, Zardi D, Nannini C, Pace B, Schiavoni M, Barbato E, Volpe M
• Primary percutaneous coronary intervention for STEMI and N-STEMI - Part II
  • Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina - comparison of the effects of drug-eluting versus bare-metal stents
    Nietlispach F, Leibundgut G, Pittl U, Brunner-La Rocca H, Kaiser C, Pfisterer M
    Feasibility and efficacy of paclitaxel-eluting stent in the patients with acute coronary syndrome: optical coherence tomography analysis
    Habara M, Terashima M, Nasu K, Kimura M, Ehara M, Kinoshita Y, Tsuchikane E, Asakura Y, Kato O, Suzuki T
    COMPARE-AMI results of 6 months follow-up comparing the everolimuseluting stent XienceV with paclitaxel-eluting stent Taxus Liberte in \"reallife\" patients presenting with ST-elevation myocardial infarction
    Kedhi E, Wassing J, van Mieghem C, Joesoef K, Mc Fadden E, Smits P
    Short term analysis of the real world usage of ENDEAVOR stents in primary PCI
    Ahmar W, Malaiapan Y, Meredith I
    Six months clinical outcomes in Nobori-STEMI Study
    Fath-Ordoubadi F, Hildick-Smith D, Carrier D, Laanmets P, Guarinos J, Jagic N, Hoffmann S, Monsegu J, Chevalier B, Danzi G
• Drug-eluting stent: registry updates - Part II
  • Five-year clinical outcomes of the arterial revascularisation therapies (ARTS-II) study of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions
    Serruys PW, Onuma Y, Garg S, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Wittebols K, Stoll H
    The comparison of sirolimus-eluting stents, paclitaxel-eluting stents and bare-metal stents in Chinese CAD patients – a meta analysis
    Xie K, Li Y, Shi H
    TiTAN2, a titanium-NO coated stent: a drug-eluting-like bare metal stent?
    Van Casteren L, Debruyne P, Vankelecom B, Roosen J, Raymenants E, De Ridder S, Janssens L
    NOBORI 2 – 6 months comparative results – on versus off label use
    Danzi G, Wiemer M, Stabile E, Ruigomez J, Koning R, Serra A, Hauptmann K, Sagic D, West N, Kala P, Wijns W
    Geographical differences in the TAXUS OLYMPIA Registry: 1-Year results in 22,000 patients
    Ahmed W, Mendiz O, Thomas M, Leadley K, Dawkins K
    The outcome of bifurcation lesion stenting using a biolimus eluting stent with a biodegradable polymer compared to a sirolimus eluting stent with a durable polymer
    Garg S, Wykrzykowska J, De Vries T, Simon W, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Conti R, Wijns W, Morice M-C, Di Mario C, Davis S, van Geuns R-J, Eerdmans P, Van Es G-A, Meier B, Juni P, Windecker S, Serruys PW
• Adjunctive therapies in percutaneous coronary intervention
  • Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on inflammatory and platelet activation markers: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent). A multicenter, open-label study
    Wykrzykowska J, Warnholtz A, De Jaeger P, Curzen N, Oldroyd K, Collet J-P, Berg J, Rademaker T, Goedhart D, Kint P-P, Serruys PW
    Long-term outcomes of patients under anti-vitamin K treatment receiving endothelial progenitor cell capture stent. Results from a single-center prospective registry
    Martin-Yuste V, Brugaletta S, Cola C, Silva B, Sabaté M
    Routine use of Fondaparinux in acute coronary syndromes. A two year, multicentre experience and a comparison with Enoxaparin
    Schiele F, Meneveau N, Perruche M, Duteil J, Chopard R, Seronde M-F, Descotes-Genon V, Bassand J-P
    High doses of atorvastatin before PCI in patient with and without chronic statin therapy
    Auguadro C, Manfredi M, Angeletti C, Scalise F, Specchia G
    Aspirin non compliance is the major cause of aspirin resistance in patients undergoing coronary stenting
    Cuisset T, Frere C, Quilici J, Poyet R, Gaborit B, Bali L, Alessi M-C, Bonnet J-L
    Predictive value of post treatment platelet reactivity for occurrence of post-discharge bleeding after non st elevation acute coronary syndrome
    Cuisset T, Cayla G, Frere C, Poyet R, Quilici J, Bali L, Morange P, Alessi M-C, Bonnet J-L
• Percutaneous coronary intervention in patients with left main stenosis
  • Culotte versus crush stenting of left main coronary artery bifurcation lesions: 14-month follow-up. Subgroup analysis of the randomised nordic bifurcation stent technique study
    Matti N, Kervinen K, Erglis A, Kumsars I, Maeng M, Lassen J, Gunnes P, Stavnes S, Jensen J, Galloe A, Narbute I, Sondroe D, Christiansen E, Ravkilde J, Steigen T, Mannsverk J, Thayssen P, Hansen K, Virtanen K, Helqvist S, Vikman S, Wiseth R, Aaroe J, Thuesen L
    Impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients
    Bollati M, Biondi-Zoccai G, Palmerini T, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, De Servi S, Sheiban I
    Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease
    Capodanno D, Di Salvo M-E, Cincotta G, Miano M, Tamburino Cl, Tamburino C
    Sex-related long-term differences after unprotected left main stenting: a multicenter Italian registry
    Cavallero E, La Spina C, Bollati M, Colombo F, Palmerini T, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, De Servi S, Sheiban I
    Do we really need routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease?
    Giraudi E, Biondi-Zoccai G, Moretti C, Sciuto F, Omedè P, Sillano D, Garrone P, Iacovino C, Trevi G-P, Sheiban I
• Innovative coronary devices - Part II
  • Stent-on-a-wire, a fixed guidewire stent delivery system, rationale, design, and development
    Fischell D, Fischell T, Fischell R
    Novel polymer-free cerivastatin eluting stent
    Birtles J, Hakimimehr D, Colley K, Venegoni A, Sotirovska N, Pendyala L, Hou D, Chronos N
    Drug eluting balloon DIOR, enhanced version
    Von Strandmann R, Hemetsberger R, Petrasi Z, Glogar D, Gyöngyösi M
    A novel mesh covered stent for the treatment of coronary artery perforation
    Jain A, Weerackody R, Rothman M
    Release kinetics & safety of sirolimus-eluting RES technology stents in the porcine coronary artery model
    Price S, Stanely J, Luk A, Sun Y-P, Dooley J, Guy L-G, Kovalcsik R, Beaudry D, Steese-Bradley G, Rogers C
    Assessment of a novel fully bioabsorbable salicylate-based sirolimus-eluting stent
    Jabara R, Chronos N, Robinson K
• Restenosis in the drug-eluting stent era
  • SES in stent restenosis: impact of pattern and treatment factors on outcomes
    Rathore S, Kinoshita Y, Terashima M, Kimura M, Tsuchikane E, Katoh O, Suzuki T
    Increase in CD34 positive cells after acute myocardial infarction may reduce late luminal loss in the stent implanted in coronary artery
    Date M, Itoh H, Iwakura K, Okamura A, Koyama Y, Higuchi Y, Inoue K, Kimura R, Nagai H, Fujii K
    Clinical and angiographic outcomes of drug eluting stent (Silolimus- and Paclitaxel- eluting stent) deployed in aorto-ostium of Right Coronary Artery
    Sakamoto Y, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, Nakano M, Yamawaki T, Araki M, Takimura H
    Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of 718 patients. The failure in left main study (FAILS)
    Sillano D, Chieffo A, Colombo A, Vecchio S, Margheri M, Gunn J, Raina T, Liistro F, Bolognese L, Lee M, Tobis J, Iacovino C, Biondi-Zoccai G, Sheiban I
    Drug-eluting stent for bare metal in-stent restenosis. Registry with long term clinical follow-up
    Berta B, Barczi G, Becker D, Fulop G, Geller L, Molnar L, Szabo G, Merkely B
• Percutaneous coronary intervention in chronic coronary total occlusion - Part I
  • Three-dimensional quantitative analysis of chronic total occlusion plaque by computed tomography: prediction of PCI success
    Choi J-H, Song Y-B, Hahn J-Y, Choi S-H, Gwon H-C, Choe Y, Lee S-H
    Procedural outcomes of hydrophilic-coated and small-sized floppy guidewires for recanalisation of chronic total occlusions
    Hasegawa K, Otsuji S, Hanyu S, Terasoma K, Fukumoto A, Ikushima M, Asano K, Hiromoto K, Yabuki M, Takiuchi S, Higashino Y
    Retrograde percutaneous recanalisation of chronic total occlusion of the coronary arteries: procedural outcomes and predictors of success in contemporary practice
    Rathore S, Katoh O, Terashima M, Matsuo H, Tanaka N, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura K, Kinoshita Y, Asakura Y, Suzuki T
    Does intraocclusion high pressure liquid injection facilitate successful coronary CTO recanalisation?
    Babunashvili A, Dundua D
    FIM study: The Ovalum CiTop™ Expander guidewire for recanalisation of coronary CTOs
    Parikh K, Shah A, Chag M, Segev A
• Primary percutaneous coronary intervention for STEMI and N-STEMI - Part III
  • Myocardial Infarction with normal or near normal coronary angiography: Intravascular Ultrasound Study of the culprit vessel
    Poyet R, Cuisset T, Bali L, Quilici J, Lambert M, Bonnet J-L
    Primary PCI in Kosovo. First experience
    Trajceski T, Petrovski Z, Brovina L, Macula S, Zuna B, Ilijazi A, Ademaj F, Palaska K, Bekteshi T, Pozari L, Avdimetaj I, Shala S, Selmanaj A, Ademaj P, Avdushi S, Shemesedin S, Petrovski B
    Wireless technology in acute ST elevation myocardial infarction
    Kaluski E, Maher J, Gerula C, Sedaghat D, Shehadeh A, Klapholz M
    Fractional flow reserve to assess severity of non-culprit stenoses in patients with acute coronary syndromes
    Ntalianis A, Sells J-W, Muller O, Trana C, Davidavicius G, Tanaka N, Barbato E, Vanderheyden M, Hamilos M, Heyndrickx G, Wijns W, Pijls N, de Bruyne B
    Difficulties in reduction of mortality in acute coronary syndromes in a regional network with a population of 1 million inhabitants with low-adherence to European guidelines
    Benedek I, Chitu M, Kovacs I, Sarbu A, Kurtinecz M, Matei C, Kozma G, Benedek Is, Madaras S, Benedek T
• Innovative coronary devices - Part III
  • Nanoparticles of sirolimus for the treatment of in-stent restenosis: Nanolimus trial
    Zago A, Raudales J, Nascimento L, Centeno P, Kosachenco B, Reginato L, Dallarosa D, Dreyer C, Bortolini M, Zago AJ
    Vascular healing response to simvastatin-eluting-stent (IRIST®) in a swine coronary model
    De Prado A, Perez C, Cuellas C, Regueiro M, Diego A, De Miguel A, Gonzalo J-M, Altonaga J, Iglesias M, Ajenjo J, Martinez B, Molina M, Duocastella L, Fernandez A, Merlos M, Fernandez-Vazquez F
    Lowering the dose of sirolimus, released from a non-polymeric hydroxy-apatite coated coronary stent, reduces signs of delayed healing
    van Beusekom H, Sorop O, Peters-Krabbendam I, Serruys PW, van der Giessen W
    Vascular biological responses of porcine coronary arteries to overlapping bioabsorbable coated low-dose paclitaxel-eluting stent
    Yin X, Shinke T, Li J, Pendyala L, Geva S, Chen J, Venegoni A, Colley K, Chronos N, Robinson K, Hou D
• Prevention of complications in percutaneous coronary intervention
  • PCI and 30-day mortality: the British Columbia PCI risk score
    Hamburger J, Walsh S, Khurana R, Ding L, Gao M, Humphries K, Carere R, Fung A, Mildenberger R, Simkus G, Webb J, Buller C
    Coronary balloon occlusions for diagnostic procedures in normal arteries: an angiographic and clinical follow-up study
    Gloekler S, Meier P, Traupe T, Seiler C
    Safe bypass intervention with the combination of embolic protection device and GPIIb/IIIa inhibition
    Bergmann M, Krämer J, Gross C
    Preliminary results on novel approach in prevention of contrast induced nephropathy
    Al Rashdan I, Al Kandary F
    Pericardium covered stent: a novel device for treatment and prevention of coronary emergencies
    Danenberg H
• Iliac, femoral and distal percutaneous interventions
  • Primary stenting for occlusive disease of the infrarenal aorta and aortic bifurcation as treatment of choice: mid-term results of 32 patients
    Schwindt A, Donas K, Pitoulias G, Torsello G
    Endovascular aortic repair with the Endurant stent-graft: a preliminary multicenter experience
    Donas K, Troisi N, Pratesi C, Torsello G
    Clinical and mid-term outcome of EVT and efficacy of MSCT mapping for Iliac CTO lesion
    Araki M, Muramatsu T, Tsukahara R, Ito Y, Sakai T, Ishimori H, Hirano K, Nakano M, Yamawaki M, Takimura H, Sakamoto Y
    Neurological complications associated with endovascular repair of thoracic aortic pathology. A single-centre experience
    Branzan D, Peck W, Pascucci S, Weinbeck M, Bürgelin K, Flügel P, Zeller T, Beyersdorf F
    Complex endovascular treatment of iliac lesions associated with multilevel arterial disease using percutaneous transluminal angioplasty, stenting and Excimer laser angioplasty. Technical results and clinical outcomes
    Benedek I, Chitu M, Kovacs I, Sarbu A, Matei C, Benedek T
• Percutaneous coronary intervention in chronic coronary total occlusion - Part II
  • Percutaneous coronary interventions in complex chronic total occlusion (CTO): success predictors and evaluation of the learning curve
    Cuevas J, Elorriaga A, Sagredo M, Gandarias J, Arrieta M, De Bobadilla A, Pereiro A, Zaldumbide E, Goya I
    Retrograde approach for percutaneous coronary interventions in chronic total occlusions. Initial experience and results.
    Rumoroso J-R, Subinas A, Sadaba M, Onaindia J-J, Telleria M, Romero A, Cacicedo A, Laraudogoitia E
    Incidence, features, and impacts of coronary perforation during CTO treatment: an angiographic substudy from the J-CTO registry
    Morino Y, Kimura T, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Kato K, Shibata Y, Hiasa Y, Doi O, Yamashita T, Abe M, Morimoto T, Mitsudo K
    Treatment of chronic total occlusions: long-term safety and efficacy of drug-eluting versus bare-metal stents
    La Spina C, Moretti C, Sciuto F, Omede P, Biondi Zoccai G, Trevi G-P, Sheiban I
    Complete revascularisation of the coronary arteries improved survival for patients with at least one chronic total coronary occlusion
    Ismail H, Hoye A
    Clinical outcome of patients with diabetes mellitus and chronic total occlusion after drug-eluting stenting followed by cilostazol treatment
    Suh J, Kim W-J, Seo H-S, Cho Y-H, Lee S-W, Lee N-H
• Primary percutaneous coronary intervention for STEMI and N-STEMI - Part IV
  • When primary percutaneous coronary intervention (PCI) fails: incidence, predictors and prognostic implications
    Dias V, Silveira J, Carvalho H, Torres S
    Effects of rosuvastatin and atorvastatin on the ApoB/ApoA1 ratio in patients with acute coronary syndrome (CENTAURUS trial)
    Alonso J, Lablanche J-M, Leone A, Merkely B, Morais J, Santini M, Eha J, Demil N, Licour M, Tardif J-C
    Angioplasty in acute myocardial infarction in patients with multivessel disease: how to reduce mortality?
    Piraino R, Calenta C, Luchessi E, Kirschmann D
    Long term clinical outcome after thrombectomy or standard angioplasty in patients with ST elevation myocardial infarction: individual patient data pooled analysis of 11 randomised trials
    De Vita M, Burzotta F, Gu Y, Isshiki T, Lefèvre T, Kaltoft A, Dudek D, Sardella G, Silva-Orrego P, Antoniucci D, De Luca L, Biondi-Zoccai G, Crea F, Zijlstra F
    The impact of failure mode and effect analysis on reducing door-to-balloon time and mortality in patients after ST-segment elevation myocardial infarction
    Huang W-C, Kuo F-Y, Mar G-Y, Cheng C-C, Tsai H-L, Chiang C-H, Chung C-C, Chiou K-R, Wann S-R, Hsiao S-H, Hsiao H-C, Lin S-K, Lee D, Chiou C-W, Yeh T-C, Huang H-R, Lai C-C, Lin S-L, Liu C-P
    Transradial primary PCI does not prolong door-to-balloon time and has less access site complications
    Malaiapan Y, Ahmar W, Prasad S, Cameron J, Meredith I
• Percutaneous coronary intervention and coronary bifurcation lesions: novelties - Part III
  • Cypher or Taxus, which stent fractures in bifurcation lesion?
    Kinoshita Y, Suzuki T, Katoh O, Matsubara T, Fujita H, Habara M
    Very long-term results comparing simple vs complex stenting strategy in the treatment of coronary bifurcation lesions
    Infantino V-A, Colombo F, Omedè P, Moretti C, Sciuto F, Biondi Zoccai G, Trevi G-P, Sheiban I
    Systematic implantation of a protective stent in the proximal main vessel before simultaneous kissing stenting: a newly modified technique for percutaneous treatment of coronary bifurcation lesions
    Isaaz K, Bayle S, Lamaud M, Robin C, Cerisier A, Richard L, Mayaud N, Sabry MH, Gerenton C, Da Costa A
    Percutaneous intervention of ostial coronary lesions using the Szabo technique: 1-year clinical results with angiographic follow-up
    Vaquerizo B, Serra A, Miranda F, Sierra G, Triano J-L, Bruguera J
    A new bifurcation stenting technique: Carina modification T stenting (CMT): clinical and angiographic data from the first 156 consecutive patients
    Al Rashdan I, Amin H
    One year clinical outcome after provisional T-stenting with the Endothelial Progenitor Cell capturing stent for bifurcation lesions
    Beijk M, Klomp M, Koch K, Henriques J, Baan J, Vis M, Tijssen J, Piek J, de Winter R
• Percutaneous coronary intervention: miscellaneous
  • Stent related death rates are higher in drug eluting stents than bare metal stents: an autopsy study
    Vorpahl M, Nakazawa G, Kolodgie F, Virmani R
    Clinical outcome after drug eluting stents compared to bare metal stents in unselected real-world population with acute myocardial infarction
    Elghanam A, Taher M, Farag N, Samir S, Hafez H
    Coronary endothelial dysfunction in a new porcine model of diabetes mellitus type 2
    van Den Heuvel M, Sorop O, De Vries R, van Beusekom H, Koopmans S-J, Duncker D, Danser J, van der Giessen W
    Coronary artery lesions of diabetic patients have distinct morphological and compositional characteristics: an intravascular ultrasound virtual histology analysis
    Abdel-Wahab M, Toelg R, Geist V, Khattab A, Liska B, Richardt G
    Fasting glucose is an independent risk factor for poor long-term outcome and is associated with enhanced platelet reactivity and low response to clopidogrel in patients with acute coronary syndrome
    Cuellas C, De Miguel A, Diego A, Fernandez-Vazquez F, Samaniego B, Alonso D, Perez De Prado A
    The use of Sirolimus-eluting Cypher Select stent in diabetic patients: a 6-month report from the e-select registry
    Bartorelli A, Abizaid A, Banning A, Dzavik V, Ellis S, Gao R, Holmes D, Jeong M-H, Legrand V, Neumann F-J, Spaulding C, Worthley S, Urban P
    Use of bare metal stents in the real world of drug eluting stents era
    Cuevas J-R, Sagredo M, Elorriaga A, MD, Arrieta M, Pereiro A, Onaindia J-J, Fernandez A, Goya I, Laraudogoitia E